Christoph Münch

3.4k total citations
46 papers, 1.5k citations indexed

About

Christoph Münch is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Christoph Münch has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Neurology, 15 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in Christoph Münch's work include Amyotrophic Lateral Sclerosis Research (29 papers), Neurogenetic and Muscular Disorders Research (15 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Christoph Münch is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (29 papers), Neurogenetic and Muscular Disorders Research (15 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Christoph Münch collaborates with scholars based in Germany, United States and Austria. Christoph Münch's co-authors include Thomas Meyer, Albert C. Ludolph, Reinhard Sedlmeier, C. Oliver Hanemann, Gabriele Stumm, André Maier, Robert Meyer, Johannes Prudlo, A.D Sperfeld and Gisela Peraus and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Christoph Münch

43 papers receiving 1.4k citations

Peers

Countries citing papers authored by Christoph Münch

Since Specialization

Citations

This map shows the geographic impact of Christoph Münch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Münch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Münch more than expected).

Fields of papers citing papers by Christoph Münch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Münch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Münch. The network helps show where Christoph Münch may publish in the future.

Co-authorship network of co-authors of Christoph Münch

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Münch. A scholar is included among the top collaborators of Christoph Münch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Münch. Christoph Münch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Shared prognostic information in amyotrophic lateral sclerosis – systematic assessment of the patients’ perception of neurofilament light chain and the ALS functional rating scale 2025 ·Neurological Research and Practice ·(unknown), André Maier, Torsten Grehl, Ute Weyen, Patrick Weydt, René Günther, Paul Lingor, Bettina Göricke, (unknown), Julian Großkreutz, Matthias Boentert, Isabell Cordts, Jochen H. Weishaupt, Johannes Dorst, Christoph Münch, Thomas Meyer, Petra Baum	0
2	User expectations and experiences of an assistive robotic arm in amyotrophic lateral sclerosis: a multicenter observational study 2024 ·SHILAP Revista de lepidopterología ·Susanne Spittel, Thomas Meyer, Ute Weyen, Torsten Grehl, Patrick Weydt, Robert Steinbach, Susanne Petri, Petra Baum, Moritz Metelmann, (unknown), Dagmar Kettemann, Jenny Nordén, Annekathrin Rödiger, (unknown), Julian Großkreutz, (unknown), Bertram Walter, Christoph Münch, André Maier	1
3	Neurofilament light‐chain response during therapy with antisense oligonucleotide tofersen in SOD1‐related ALS: Treatment experience in clinical practice 2023 ·Muscle & Nerve ·Thomas Meyer, (unknown), Patrick Weydt, Susanne Petri, (unknown), Susanne Spittel, Sarah Bernsen, René Günther, Jochen H. Weishaupt, (unknown), (unknown), Dagmar Kettemann, Jenny Nordén, Matthias Boentert, (unknown), Christian Meisel, Christoph Münch, André Maier, Peter Körtvélyessy	53
4	Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD) 2019 ·BMC Neurology ·Thomas Meyer, Andreas Funke, Christoph Münch, Dagmar Kettemann, André Maier, Bertram Walter, (unknown), Susanne Spittel	39
5	Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis—A Pilot Study 2015 ·PLoS ONE ·André Maier, Nikolaus Deigendesch, Kathrin Müller, Jochen H. Weishaupt, Alexander Krannich, Robert Röhle, Felix Meissner, Kaaweh Molawi, Christoph Münch, Teresa M. Holm, Robert Meyer, Thomas Meyer, Arturo Zychlinsky	53
6	Thalidomide causes sinus bradycardia in ALS 2008 ·Journal of Neurology ·Thomas Meyer, André Maier, Nadja Borisow, (unknown), (unknown), Stephanie Ohlraun, Christoph Münch, (unknown)	26
7	Elektive Termination der Beatmungstherapie bei der amyotrophen Lateralsklerose 2008 ·Der Nervenarzt ·Thomas Meyer, (unknown), Christoph Münch, (unknown), E. Hempel, Simone Rosseau, Nadja Borisow, (unknown)	16
8	Heterozygous S44L missense change of the spastin gene in amyotrophic lateral sclerosis 2008 ·Amyotrophic Lateral Sclerosis ·Christoph Münch, Arndt Rolfs, Thomas Meyer	15
9	Progressive Muskelatrophie 2007 ·Der Nervenarzt ·Thomas Meyer, Christoph Münch, Frank K.H. van Landeghem, Nadja Borisow, (unknown), (unknown)	3
10	The p150 subunit of dynactin (DCTN1) gene in multiple sclerosis 2007 ·Acta Neurologica Scandinavica ·Christoph Münch, Roman Meyer, (unknown), Thomas Meyer, Albert C. Ludolph, Jürgen Haas, Bernhard Hemmer	4
11	Chemical Hypoxia Facilitates Alternative Splicing of EAAT2 in Presymptomatic APP23 Transgenic Mice 2007 ·Neurochemical Research ·Christoph Münch, (unknown), (unknown), (unknown), Matthias W. Riepe, Albert C. Ludolph, Thomas Meyer	12
12	Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus 2007 ·Journal of the Neurological Sciences ·Christoph Münch, (unknown), Robert Meyer, Judith Haas	36
13	Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD 2005 ·Annals of Neurology ·Christoph Münch, Angela Rosenbohm, Anne‐Dorte Sperfeld, Ingo Uttner, Sven N. Reske, Bernd J. Krause, Reinhard Sedlmeier, Thomas Meyer, C. Oliver Hanemann, Gabriele Stumm, Albert C. Ludolph	138
14	Frequency of a tau genotype in amyotrophic lateral sclerosis 2005 ·Journal of the Neurological Sciences ·Christoph Münch, (unknown), Renshi Xu, (unknown), Johannes Prudlo, Magdalena Kuźma‐Kozakiewicz, Hubert Kwieciński, Albert C. Ludolph, Thomas Meyer	10
15	Alternative splicing of the 5′‐sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis 2002 ·Journal of Neurochemistry ·Christoph Münch, (unknown), (unknown), Benzhong Zhu, Stefan Stamm, G. Bernhard Landwehrmeyer, Albert C. Ludolph, Birgit Schwalenstöcker, Thomas Meyer	36
16	Impaired RNA splicing of 5'-regulatory sequences of the astroglial glutamate transporter EAAT2 in human astrocytoma 2001 ·Journal of Neurology Neurosurgery & Psychiatry ·Christoph Münch	22
17	Differential RNA cleavage and polyadenylation of the glutamate transporter EAAT2 in the human brain 2000 ·Molecular Brain Research ·Christoph Münch, Birgit Schwalenstöcker, (unknown), (unknown), Stefan Stamm, Albert C. Ludolph, Thomas Meyer	18
18	The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals 1999 ·Journal of the Neurological Sciences ·Thomas Meyer, (unknown), Christoph Münch, Birgit Schwalenstöcker, Anne E. Fray, Paul G. Ince, Stefan Stamm, Georg Grön, Albert C. Ludolph, Pamela J. Shaw	105
19	NEUROTOXIC MECHANISMS OF DEGENERATION IN MOTOR NEURON DISEASES* 1999 ·Drug Metabolism Reviews ·Albert C. Ludolph, Christoph Münch	6
20	5′-Heterogeneity of the human excitatory amino acid transporter cDNA EAAT2 (GLT-1) 1998 ·Neuroreport ·Christoph Münch, Birgit Schwalenstöcker, (unknown), (unknown), (unknown), Albert C. Ludolph, Thomas Meyer	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact